[Management of colorectal liver metastases after induction treatment. The pathologist's role in 2011]

Ann Pathol. 2011 Dec;31(6):427-32. doi: 10.1016/j.annpat.2011.10.001. Epub 2011 Nov 22.
[Article in French]

Abstract

The management of colorectal liver metastases has been improved these last years. The efficacy of chemotherapy regimens and targeted therapies has led to a better prognosis. It has also allowed the resection of metastases initially unresectable. In this setting, the pathologist plays a major role. He is involved in the gross examination, in order to perform an adequate sampling of the lesions. He is also involved at the morphological level, for the assessment of the pathological response, which is now recognized as a prognostic factor and a marker of sensitivity or resistance to a given treatment. Moreover, the determination of predictive markers of response or resistance to induction treatments will constitute a supplementary and major challenge for the pathologist.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma / chemistry
  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / secondary*
  • Adenocarcinoma / surgery
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor / analysis
  • Chemical and Drug Induced Liver Injury / etiology
  • Colorectal Neoplasms / pathology*
  • Combined Modality Therapy
  • Disease Management
  • Humans
  • Induction Chemotherapy*
  • Interdisciplinary Communication
  • Liver Neoplasms / chemistry
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary*
  • Liver Neoplasms / surgery
  • Molecular Targeted Therapy
  • Neoplasm Grading
  • Pathology, Clinical*
  • Physician's Role*
  • Prognosis
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor